Norcross, GA ? July 1, 2013 - (eTeligis via ACCESSWIRE) -- RayBiotech, Inc. announced today their sponsorship of a new funding opportunity for biomedical science researchers, a program called the "2013 RayBiotech Innovative Research Grant." Terms of the grant program state that eligible topics include studies on model systems for biological processes and disease, biomarker discovery and validation, biomedical and veterinary sciences, biotechnology and biological sciences (including biochemistry, cell biology, genetics, physiology, plant sciences, environmental sciences, nutrition and food sciences). The highest scoring applicants will receive up to $15,000 worth of RayBiotech products, which include antibody arrays, ELISA kits, reagents, and custom services. The grant program is open to researchers worldwide.
RayBiotech's President, Chief Operating Officer and Co-Founder, Rani Huang stated, "We are excited to have the opportunity to give something back to the research community that we serve. Our products have enabled thousands of researchers to describe the molecular basis of disease, resulting in many high-impact publications. This grant program will help us to fulfill our mission of the advancement of personalized medicine." The applicants will be scored on scientific merit, potential impact of the proposed research, and degree of creativity or inventiveness exhibited in the project.
About RayBiotech, Inc.
In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets. RayBiotech products are featured in thousands of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in the metropolitan Atlanta area.
For More Information:
Rob Burgess, PhD
Director, Business Development
SOURCE: RayBiotech, Inc.